PMV Pharmaceuticals, Inc. (PMVP) Misses Q2 EPS by 2c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q2 EPS of ($0.41), $0.02 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Silver Lake In Talks To Buy Workday, Sources Say - Reuters
• PM Super Fund Reveals Marilia Bento, Chair of the Special Committee Refuses Cross Examination, Catherine Stretch Owned Shares in Parent Company of MGLIT, and Sets Record Straight on Matters in Emerita
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c